Physician profile
Jeffrey Simon Lander
NPI 1356533889
$5,250.98
in general payments reported to CMS, 2019-2025
35 companies · $1,102 in 2025
The $1,102 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $98.97 · 2021: $642 · 2022: $700 · 2023: $1,279 · 2024: $1,080 · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,461.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,128.80 | 2019-2025 | Leqvio |
| Amgen INC. | $670.71 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $506.87 | 2021-2025 | Verquvo |
| Pfizer INC. | $387.66 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $305.12 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $240.31 | 2019-2025 | Watchman Flx, Cds - Mct/Cem Monitoring, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $171.10 | 2023-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $161.84 | 2019-2022 | |
| Philips North America LLC | $160.92 | 2022-2025 | (Ck4) Mcot, Extended Holter |
| Sanofi-Aventis U.S. LLC | $155.67 | 2019-2024 | |
| Cvrx, INC. | $146.55 | 2023-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $142.12 | 2019-2024 | Farxiga |
| Amarin Pharma, INC. | $128.93 | 2019-2022 | |
| Heartflow, INC. | $127.91 | 2024-2025 | |
| Baxter Healthcare | $122.22 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.